Coda Biotherapeutics Overview
- Year Founded
-
2014
- Status
-
Out of Business
- Employees
-
32
- Latest Deal Type
-
Out of Business
Coda Biotherapeutics General Information
Description
Developer of chemogenetic technology designed to treat neuropathic pain, epilepsy, movement disorders, and other severe nervous system disorders. The company's technology utilizes viral vectors and engineered neurotransmitters to target neurons and reduces pain, enabling healthcare providers to treat nervous system disorders with greater efficiency than traditional therapies.
Contact Information
Website
www.codabiotherapeutics.comCorporate Office
- 240 East Grand Avenue
- 1st Floor
- South San Francisco, CA 94080
- United States
Corporate Office
- 240 East Grand Avenue
- 1st Floor
- South San Francisco, CA 94080
- United States
Coda Biotherapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Out of Business | Completed | Out of Business | ||||
| 6. Later Stage VC | 02-Dec-2021 | Completed | Pre-Clinical Trials | |||
| 5. Grant | 10-Nov-2020 | Completed | Pre-Clinical Trials | |||
| 4. Grant | 30-Sep-2020 | Completed | Pre-Clinical Trials | |||
| 3. Later Stage VC (Series A) | 05-Nov-2019 | Completed | Pre-Clinical Trials | |||
| 2. Accelerator/Incubator | 15-Jun-2017 | $10M | Completed | Pre-Clinical Trials | ||
| 1. Early Stage VC (Series A) | 31-Mar-2017 | $10M | $10M | Completed | Startup |
Coda Biotherapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A |
Coda Biotherapeutics Comparisons
Industry
Financing
Details
Coda Biotherapeutics Competitors (41)
One of Coda Biotherapeutics’s 41 competitors is CervoMed, a Formerly VC-backed company based in Boston, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| CervoMed | Formerly VC-backed | Boston, MA | ||||
| GenSight Biologics | Formerly VC-backed | Paris, France | ||||
| ONL Therapeutics | Venture Capital-Backed | Ann Arbor, MI | ||||
| Coave Therapeutics | Venture Capital-Backed | Paris, France | ||||
| Verge Labs | Venture Capital-Backed | San Francisco, CA |
Coda Biotherapeutics Patents
Coda Biotherapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20250152742-A1 | Compositions and methods for neurological diseases | Pending | 18-Feb-2022 | ||
| US-20240108760-A1 | Adeno-associated virus capsids and engineered ligand-gated ion channels for treating focal epilepsy and neuropathic pain | Pending | 25-Jan-2021 | ||
| WO-2022159871-A1 | Adeno-associated virus capsids and engineered ligand-gated ion channels for treating focal epilepsy and neuropathic pain | Inactive | 25-Jan-2021 | ||
| WO-2022040535-A2 | Compositions and methods for neurological diseases | Inactive | 21-Aug-2020 | ||
| WO-2022040535-A3 | Compositions and methods for neurological diseases | Inactive | 21-Aug-2020 | A61P25/00 |
Coda Biotherapeutics Signals
Coda Biotherapeutics Acquisitions (1)
Coda Biotherapeutics’s most recent deal was a Merger/Acquisition with Attenua. The deal was made on 05-Feb-2020.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Attenua | 05-Feb-2020 | Merger/Acquisition | Drug Discovery |
Coda Biotherapeutics FAQs
-
When was Coda Biotherapeutics founded?
Coda Biotherapeutics was founded in 2014.
-
Where is Coda Biotherapeutics headquartered?
Coda Biotherapeutics is headquartered in South San Francisco, CA.
-
What is the size of Coda Biotherapeutics?
Coda Biotherapeutics has 32 total employees.
-
What industry is Coda Biotherapeutics in?
Coda Biotherapeutics’s primary industry is Drug Discovery.
-
Is Coda Biotherapeutics a private or public company?
Coda Biotherapeutics is a Private company.
-
What is Coda Biotherapeutics’s current revenue?
The current revenue for Coda Biotherapeutics is .
-
How much funding has Coda Biotherapeutics raised over time?
Coda Biotherapeutics has raised $72M.
-
Who are Coda Biotherapeutics’s competitors?
CervoMed, GenSight Biologics, ONL Therapeutics, Coave Therapeutics, and Verge Labs are some of the 41 competitors of Coda Biotherapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process